Cosmina Hogea

Biased efficacy estimates in phase-III dengue vaccine trials due to heterogeneous exposure and differential detectability of primary infections across trial arms

Guido España, Cosmina Hogea, Adrienne Guignard et al. · PLoS ONE · 2019 · 734 citations · Full text

Vaccination, Dengue Vaccine Candidates, Infectious Disease Modelling +14

An image-driven parameter estimation problem for a reaction–diffusion glioma growth model with mass effects

Cosmina Hogea, Christos Davatzikos, George Biros · Journal of Mathematical Biology · 2007 · 247 citations · Full text

Radiation Oncology, Engineering, Health Sciences +11

Increasing Role of <i>Staphylococcus aureus</i> and Community-Acquired Methicillin-Resistant <i>Staphylococcus aureus</i> Infections in the United States: A 10-Year Trend of Replacement and Expansion

Robertino M. Mera, Jose A. Suaya, Heather Amrine‐Madsen et al. · Microbial Drug Resistance · 2011 · 98 citations

Simulating complex tumor dynamics from avascular to vascular growth using a general level-set method

Cosmina Hogea, Bruce T. Murray, James A. Sethian · Journal of Mathematical Biology · 2006 · 83 citations

Vascular Growth, Angiogenesis, Complex Tumor Dynamics +12

Non-diffeomorphic registration of brain tumor images by simulating tissue loss and tumor growth

Evangelia I. Zacharaki, Cosmina Hogea, Dinggang Shen et al. · NeuroImage · 2009 · 77 citations

Non-diffeomorphic Registration, Neuro-oncology, Engineering +15